Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

[1]  John Quackenbush,et al.  Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. , 2016, JCI insight.

[2]  D. Hunter,et al.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. , 2015, Human molecular genetics.

[3]  David N. Rider,et al.  Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. , 2015, Journal of the National Cancer Institute.

[4]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[5]  Yurii B. Shvetsov,et al.  Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer , 2015, Nature Communications.

[6]  Dong Liang,et al.  Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[7]  S. Gayther,et al.  PAX8 expression in ovarian surface epithelial cells. , 2015, Human pathology.

[8]  Jianfeng Xu,et al.  Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk‐associated loci , 2015, The Prostate.

[9]  Yurii B. Shvetsov,et al.  Identification of six new susceptibility loci for invasive epithelial ovarian cancer , 2015, Nature Genetics.

[10]  M. Zannini,et al.  A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells , 2014, BMC Cancer.

[11]  Bairong Shen,et al.  Post genome-wide association studies functional characterization of prostate cancer risk loci , 2013, BMC Genomics.

[12]  Gregory A. Wyant,et al.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer cell.

[13]  Kerstin B. Meyer,et al.  Master regulators of FGFR2 signalling and breast cancer risk , 2013, Nature Communications.

[14]  L. Aaltonen,et al.  Lessons from functional analysis of genome-wide association studies. , 2013, Cancer research.

[15]  W. Bickmore,et al.  Regulation from a distance: long-range control of gene expression in development and disease , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  Nathan L. Tintle,et al.  Assessing Methods for Assigning SNPs to Genes in Gene-Based Tests of Association Using Common Variants , 2013, PloS one.

[17]  Brooke L. Fridley,et al.  GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.

[18]  Wei Lu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[19]  W. Chung,et al.  Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.

[20]  Swneke D. Bailey,et al.  Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression , 2012, Nature Genetics.

[21]  A. Butte,et al.  Leveraging models of cell regulation and GWAS data in integrative network-based association studies , 2012, Nature Genetics.

[22]  Richard S. Sandstrom,et al.  BEDOPS: high-performance genomic feature operations , 2012, Bioinform..

[23]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[24]  Colm O'Dushlaine,et al.  INRICH: interval-based enrichment analysis for genome-wide association studies , 2012, Bioinform..

[25]  T. Bailey,et al.  Inferring direct DNA binding from ChIP-seq , 2012, Nucleic acids research.

[26]  M. Marazita,et al.  Genome-wide Association Studies , 2012, Journal of dental research.

[27]  N. Traficante,et al.  The Australian Ovarian Cancer Study , 2012, Hereditary Cancer in Clinical Practice.

[28]  Inge Jonassen,et al.  Linkage-disequilibrium-based binning affects the interpretation of GWASs. , 2012, American journal of human genetics.

[29]  J. Carpten,et al.  Association of prostate cancer risk with snps in regions containing androgen receptor binding sites captured by ChIP‐On‐chip analyses , 2012, The Prostate.

[30]  L. Truong,et al.  PAX2 and PAX8 Expression in Primary and Metastatic Müllerian Epithelial Tumors: A Comprehensive Comparison , 2011, The American journal of surgical pathology.

[31]  Qian Wang,et al.  A comprehensive view of nuclear receptor cancer cistromes. , 2011, Cancer research.

[32]  J. Mesirov,et al.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer , 2011, Proceedings of the National Academy of Sciences.

[33]  L. Truong,et al.  PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study , 2011, Modern Pathology.

[34]  C. Carlson,et al.  Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.

[35]  R. Vierkant,et al.  LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. , 2011, Cancer research.

[36]  A. Whittemore,et al.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.

[37]  A. Whittemore,et al.  Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.

[38]  Ayellet V. Segrè,et al.  Common Inherited Variation in Mitochondrial Genes Is Not Enriched for Associations with Type 2 Diabetes or Related Glycemic Traits , 2010, PLoS genetics.

[39]  R. Eils,et al.  Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3 , 2010, BMC Genomics.

[40]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[41]  A. Whittemore,et al.  A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.

[42]  E. Winterhager,et al.  Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. , 2007, Endocrinology.

[43]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[44]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Roden,et al.  A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Melissa C. Greven,et al.  An integrated encyclopedia of DNA elements in the human genome , 2014 .

[48]  Sebastian M. Armasu,et al.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17 q 21 . 31 , 2013 .

[49]  R. Vierkant,et al.  LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer , 2011 .

[50]  Nicholas G Martin,et al.  Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. , 2007, Human molecular genetics.

[51]  J. Epstein,et al.  Getting your Pax straight: Pax proteins in development and disease. , 2002, Trends in genetics : TIG.

[52]  Howard C. Shen,et al.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 , 2022 .